Filing Flows › Comparisons › SNOA vs PREM
Sonoma Pharmaceuticals vs Premier Air Charter Holdings: SNOA and PREM compared
Sonoma Pharmaceuticals is the larger company: $6.4M of revenue in its latest quarter (Q1 FY27) against $5.8M for Premier Air Charter Holdings (Q2 2026). Sonoma Pharmaceuticals is growing faster (+60% against -22% a year earlier). Sonoma Pharmaceuticals is more profitable, with an operating margin of -0.6% against -15.7%.
Where the money goes: SNOA and PREM
Sonoma Pharmaceuticals (SNOA) · Q1 FY27
Sonoma Pharmaceuticals, Q1 FY27: revenue $6.4M (+60% year over year), operating margin -0.6%, net loss $330K, operating cash flow −$649K. The chart follows the revenue to costs, profit and cash.
Premier Air Charter Holdings (PREM) · Q2 2026
Premier Air Charter Holdings, Q2 2026: revenue $5.8M (-22% year over year), operating margin -15.7%, net loss $1.3M, operating cash flow $318K. The chart follows the revenue to costs, profit and cash.
| Sonoma Pharmaceuticals (SNOA) | Premier Air Charter Holdings (PREM) | |
|---|---|---|
| Latest quarter | Q1 FY27 | Q2 2026 |
| Revenue | $6.4M | $5.8M |
| Revenue growth, Y/Y | +60% | -22% |
| Operating margin | -0.6% | -15.7% |
| Net earnings | −$330K | −$1.3M |
| Net margin | -5.2% | -22.3% |
| Operating cash flow | −$649K | $318K |
Questions
Which is bigger, Sonoma Pharmaceuticals or Premier Air Charter Holdings?
Sonoma Pharmaceuticals is the larger company: $6.4M of revenue in its latest quarter (Q1 FY27) against $5.8M for Premier Air Charter Holdings (Q2 2026).
Is Sonoma Pharmaceuticals or Premier Air Charter Holdings growing faster?
Sonoma Pharmaceuticals is growing faster (+60% against -22% a year earlier).
Which is more profitable, Sonoma Pharmaceuticals or Premier Air Charter Holdings?
Sonoma Pharmaceuticals is more profitable, with an operating margin of -0.6% against -15.7%.
More: Sonoma Pharmaceuticals earnings · how Sonoma Pharmaceuticals makes money · Premier Air Charter Holdings earnings · how Premier Air Charter Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 6, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.